Angiotensin-converting enzyme (ACE) inhibitors a review of the comparative clinical and cost-effectiveness

This purpose of this report is to update a 2008 CADTH Rapid Response report on the comparative clinical and cost-effectiveness of angiotensin converting enzyme (ACE) inhibitors. In addition, it aims to examine the effectiveness of the combination of ACE inhibitors and diuretics compared to ACE inhib...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: [Ottawa] Canadian Agency for Drugs and Technologies in Health 12 June 2015, 2015
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01930nam a2200325 u 4500
001 EB001839674
003 EBX01000000000000001003663
005 00000000000000.0
007 tu|||||||||||||||||||||
008 180702 r ||| eng
245 0 0 |a Angiotensin-converting enzyme (ACE) inhibitors  |h Elektronische Ressource  |b a review of the comparative clinical and cost-effectiveness 
246 3 1 |a ACE inhibitors 
260 |a [Ottawa]  |b Canadian Agency for Drugs and Technologies in Health  |c 12 June 2015, 2015 
300 |a 1 PDF file (21 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Hypertension / drug therapy 
653 |a Comparative Effectiveness Research 
653 |a Angiotensin-Converting Enzyme Inhibitors / therapeutic use 
653 |a Cost-Benefit Analysis 
653 |a Myocardial Infarction / drug therapy 
653 |a Diabetic Nephropathies / drug therapy 
653 |a Diuretics / therapeutic use 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Rapid response report: summary with critical appraisal 
500 |a Title from PDF caption title 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK304523  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a This purpose of this report is to update a 2008 CADTH Rapid Response report on the comparative clinical and cost-effectiveness of angiotensin converting enzyme (ACE) inhibitors. In addition, it aims to examine the effectiveness of the combination of ACE inhibitors and diuretics compared to ACE inhibitors alone. The finding of this report can help produce clinical evidence as well as policy directions on the best and optimum use of individual ACE inhibitors for hypertension (HTN), heart failure (HF), myocardial infarction (MI), and diabetic nephropathy